Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:26:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the ClinicalTrials.gov page, announcing a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-26T15:44:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 error, and its footer revision marker changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T15:45:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:42:07.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. This indicates access to the study details is blocked, with the usual navigation and study information not shown.
    Difference
    20%
    Check dated 2026-09-21T20:32:51.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a small version update to the page.
    Difference
    0.0%
    Check dated 2026-08-31T16:18:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.